Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arthrokehlan A is an isopathic/homeopathic remedy developed and manufactured by SANUM-Kehlbeck. [9] The active ingredient is a sterile, lyophilized filtrate derived from cultures of the bacterium Propionibacterium (Cutibacterium) acnes, prepared in homeopathic dilutions such as 6X or D6. [1, 2] Within the SANUM therapy system, it is classified as an immune-regulation medicine. [15] While no specific therapeutic indications are officially stated by the manufacturer, it is used supportively for arthritic and degenerative joint conditions like arthrosis, as well as myalgia. [1, 2, 4] The mechanism of action follows isopathic/homeopathic principles rather than targeting a specific molecular pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Arthrokehlan A.